SEATTLE — Molecular testing has been widely integrated into mainstream healthcare, and its use is increasing in dermatology. It can help differentiate between skin conditions, for example, as some ...

Virginia Sybert, MD, clinical professor of medical genetics at the University of Washington, discussed what dermatologists should know about molecular testing in clinical practice. Virginia Sybert, MD ...

In the following sections, we highlight ethical concerns about early adoption of molecular diagnostic testing without solid evidence or guidelines and offer practical guidance for ethical ...

Molecular testing, including chromosomal microarray analysis, distinguishes between aggressive and indolent kidney cancer subtypes, aiding in accurate diagnosis. Accurate diagnosis is critical for ...

A new, evidenced-based clinical practice guideline on molecular biomarker testing for patients with colorectal cancer identifies opportunities for improving patient outcomes. This pivotal guideline ...

A panelist discusses how education and cost are key challenges in ensuring comprehensive molecular testing is performed in a timely manner for patients with ovarian cancer, emphasizing the need for ...

New PCR-based approaches simplify molecular testing for health issues in infants, making diagnostic approaches simpler and more accessible across laboratories. The Eonis™ Q system from Revvity is an ...

BATON ROUGE, La., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, is now offering advanced molecular ...

Closing rural diagnostic gap, HealthTrackRx delivers next-morning PCR test results nationwide to improve infection diagnosis and treatment.

Noninvasive surveillance with multitarget stool DNA testing or fecal immunochemical testing (FIT) could potentially match colonoscopy for reducing long-term colorectal cancer (CRC) incidence and ...

Molecular You, a Vancouver, B.C., healthy longevity company, announced today that it has raised $5 million from investors. The company offers testing for a slate of 250 biomarkers that can provide ...